Standard hormone replacement often fails to account for the enzymatic “fate” of steroid precursors. This review by Carol Petersen, RPh, CNP, explores the critical male hormonal enzymatic pathways, specifically 5-alpha and 5-beta reductase, emphasizing the conversion of progesterone to allopregnanolone for neurological stability. By moving beyond simple testosterone replacement, practitioners can better address complex cases of neurosteroid depletion and metabolic stagnation.
Carol Petersen
Home »Hormones on a Methylation Leash: Calming the Endocrine Storm
Methylation is the biochemical maestro orchestrating a symphony of processes in the body, from gene expression to hormonal harmony. This subtle yet powerful mechanism involves adding methyl groups—tiny chemical tags—to molecules, influencing how genes behave and how hormones function. It’s a linchpin for keeping estrogens, progesterone, adrenaline, histamine, thyroid hormones, testosterone, and DHEA in check. …
In Memory of Dr. Ronald P. Drucker
Ronald Peter Drucker 11 September, 1949 – 12 August, 2024 We lost a friend and a pioneer with the wellness and healthy aging community. In Memoriam Dr. Ronald P. Drucker, B.S. (M.T.A.S.C.P.), D.C. received a Bachelor of Science in Medical Technology from Long Island University and Glen Cove Community Hospital B.S. in Medical Technology, Additionally …
Revolutionary Breakthrough: Eli Lilly’s Next-Generation Drug Achieves Unprecedented 24% Weight Loss in Clinical Trials
Introduction: The Future of Weight Loss – Eli Lilly’s Groundbreaking Next-Generation Drug Eli Lilly weight loss drug, next-generation weight loss drug, breakthrough weight loss treatment, clinical trials for weight loss Introduction: In the ever-evolving field of weight loss treatments, pharmaceutical giant Eli Lilly has made waves with its groundbreaking next-generation drug. With obesity rates on …